Attached files
| file | filename |
|---|---|
| 10-K - 10-K - EKSO BIONICS HOLDINGS, INC. | ekso1231201910-k.htm |
| EX-32.2 - EXHIBIT 32.2 - EKSO BIONICS HOLDINGS, INC. | exhibit32212312019.htm |
| EX-32.1 - EXHIBIT 32.1 - EKSO BIONICS HOLDINGS, INC. | exhibit32112312019.htm |
| EX-31.2 - EXHIBIT 31.2 - EKSO BIONICS HOLDINGS, INC. | exhibit31212312019.htm |
| EX-31.1 - EXHIBIT 31.1 - EKSO BIONICS HOLDINGS, INC. | exhibit31112312019.htm |
| EX-21.1 - EXHIBIT 21.1 - EKSO BIONICS HOLDINGS, INC. | exhibit21112312019.htm |
| EX-10.37 - EXHIBIT 10.37 - EKSO BIONICS HOLDINGS, INC. | exhibit1037.htm |
| EX-10.28 - EXHIBIT 10.28 - EKSO BIONICS HOLDINGS, INC. | exhibit1028.htm |
| EX-10.11 - EXHIBIT 10.11 - EKSO BIONICS HOLDINGS, INC. | exhibit1011.htm |
| EX-4.9 - EXHIBIT 4.9 - EKSO BIONICS HOLDINGS, INC. | exhibit49.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements on Form S-8 (No. 333-198357, No. 333-207131, No. 333-220808, No. 333-222663, No. 333-226037, No. 333-230404, No. 333-232512 and No. 333-236412) and Form S-3 (No. 333-195783, No. 333-218517 and No. 333-220807) of Ekso Bionics Holdings, Inc. of our reports dated February 27, 2020, relating to the consolidated financial statements (which report expresses an unqualified opinion and includes an explanatory paragraph related to substantial doubt about the Company’s ability to continue as a going concern) and the effectiveness of internal control over financial reporting of Ekso Bionics Holdings, Inc. which appear in this Annual Report on Form 10-K.
/s/ OUM & CO. LLP
San Francisco, California
February 27, 2020